Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07137949 · ClinicalTrials.gov registry record · NA

Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care

A NA study of Delirium, sponsored by Boston Medical Center.

Recruiting
Registry status
NA
Development phase
30
Enrollment target
1
Study location

NCT07137949 is a NA study of Delirium that is actively recruiting participants, run by Boston Medical Center. The registered enrollment target is 30 participants, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07137949, a NA study of Delirium, is actively recruiting participants, sponsored by Boston Medical Center.

RECRUITING
Registry status
NA
Development phase
30 participants
Enrollment target
1
Study location

Study Summary

In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease. Each of the anticipated 30 participants will have up to five music therapy sessions. The sessions will be made just for them and may include live music, playing instruments, or listening to recorded music. Surveys will be used to learn how easy the therapy is to do in the hospital and what people think about how helpful the sessions may be for future patients.

Conditions Studied

Interventions

  • BEHAVIORAL Music therapy

Study Locations (1)

Massachusetts

  • Boston Medical Center - Boston

Trial Details

FieldValue
Enrollment Target 30 participants
Start Date 2026-03
Est. Completion 2026-12
Phase NA

Sponsor

Boston Medical Center

253 total trials

What the Registry Record Tells You About NCT07137949

The ClinicalTrials.gov registry entry for NCT07137949 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 887-participant average among 62 other Delirium trials with a reported enrollment target (97% lower). The listed sponsor is Boston Medical Center, which has 253 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Delirium appearing as the primary indexed condition, and to 1 intervention - of which Music therapy is the first listed.

NCT07137949 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT07137949 about?

NCT07137949 is a clinical study titled "Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care". In this pilot study a new kind of music therapy will be created and tested to help prevent confusion, called delirium, that can happen in the hospital. This can affect people with brain diseases like Alzheimer's disease and Parkinson's disease. Each of the anticipated 30 participants will have up t...

What is the current status of trial NCT07137949?

This trial is currently recruiting. It is a NA study. The enrollment target is 30 participants. The study started on 2026-03. Estimated completion is 2026-12.

What conditions does trial NCT07137949 study?

This clinical trial studies the following conditions: Delirium.

What interventions are being tested in trial NCT07137949?

The interventions under investigation include: Music therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT07137949?

This trial is sponsored by Boston Medical Center, which has 253 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07137949 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Delirium

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.